TY - JOUR SP - 1 AV - public SN - 1465-542X Y1 - 2015/// ID - heidok19487 VL - 17 JF - Breast Cancer Research CY - London UR - https://archiv.ub.uni-heidelberg.de/volltextserver/19487/ A1 - Widschwendter, Peter A1 - Friedl, Thomas WP A1 - Schwentner, Lukas A1 - DeGregorio, Nikolaus A1 - Jäger, Bernadette A1 - Schramm, Amelie A1 - Bekes, Inga A1 - Deniz, Miriam A1 - Lato, Krisztian A1 - Weissenbacher, Tobias A1 - Kost, Bernd A1 - Andergassen, Ulrich A1 - Jückstock, Julia A1 - Neugebauer, Julia A1 - Trapp, Elisabeth A1 - Fasching, Peter A. A1 - Beckmann, Matthias W. A1 - Schneeweiß, Andreas A1 - Schrader, Ines A1 - Rack, Brigitte A1 - Janni, Wolfgang A1 - Scholz, Christoph N2 - Introduction: Obese breast cancer patients have worse prognosis than normal weight patients, but the level at which obesity is prognostically unfavorable is unclear. Methods: This retrospective analysis was performed using data from the SUCCESS A trial, in which 3754 patients with high-risk early breast cancer were randomized to anthracycline- and taxane-based chemotherapy with or without gemcitabine. Patients were classified as underweight/normal weight (body mass index (BMI)?